BCR and metastatic melanoma: Patients with shorter OS showed enhanced levels of CD79b, part of the B-cell receptor complex (BCR), implicating an elevation of B-lymphocytes in LNs resected from stage III metastatic melanoma patients with poor survival outcomes.